RECENT ANNOUNCEMENTS

• Aug 30, 2010
  Pre and Post-Operative Use of Caldolor(R) (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
• July 12, 2010
  Caldolor(R) (Ibuprofen) Injection Shown to Significantly Reduce Fever in Malaria Patients in Newly Published Clinical Trial
• Apr 28, 2010
  Cumberland Pharmaceuticals Partners in Canada With Alveda Pharmaceuticals to Commercialize Caldolor(R)
• Apr 13, 2010
  Ibuprofen Compares Favorably to Acetaminophen in Newly Published Meta-Analysis
• Mar 04, 2010
  Key Caldolor(R) Orthopedic Data to Be Presented at American Academy of Orthopaedic Surgeons' Annual Meeting – Click here to download a copy of the presentation poster.
• Mar 02, 2010
  New Data from Caldolor(R) Study in Burn Patients to be Presented at 42nd Annual Meeting of The American Burn Association – Click here to download a copy of the presentation poster.
• Jan 20, 2010
  Cumberland Pharmaceuticals donates Caldolor(R) to Haitian Relief Effort
• Jan 05, 2010
  Caldolor(R) Data to Be Presented During Critical Care Conference in Miami Beach, Florida on January 12, 2010
• Dec 09, 2009
  Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea
• Dec 03, 2009
  New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting
• Nov 23, 2009
  Caldolor(R) (Ibuprofen) Injection Demonstrates Significant Fever Reduction in Hospitalized Burn Patients
• Oct 19, 2009
  Newly Published Clinical Data Shows Caldolor(R) (Ibuprofen) Injection Reduces Opioid Use While Improving Pain Relief in Post-Operative Patients
• Oct 05, 2009
  Cumberland Pharmaceuticals Announces Presentation of Caldolor Data at American Academy of Pain Management Meeting

EVENTS

• Dec 7, 2009
  44th American Society of Health-System Pharmacists Meeting - New Caldolor (ibuprofen) Injection Data to Be Presented
  Click here to download a copy of the presentation poster.
• Oct 10, 2009
  American Academy of Pain Management's (AAPM) 20th Annual Clinical Meeting
  Click here to download a copy of the presentation posters. Poster One | Poster Two

IMPORTANT SAFETY INFORMATION

CALDOLOR should be used with caution in patients with congestive heart failure, kidney impairment, at risk of blood clots, and in those who have a history of ulcers or gastrointestinal bleeding. When used in such patients, attention to using the lowest effective dose for the shortest time period is important to reduce the risk of serious adverse events. Ibuprofen has been associated with high blood pressure, serious skin reactions, and serious allergic reactions.

The most common adverse events reported in the controlled clinical trials were nausea, flatulence, vomiting, and headache.